AGNO PHARMA Trademark

Trademark Overview


On Monday, October 7, 2024, a trademark application was filed for AGNO PHARMA with the United States Patent and Trademark Office. The USPTO has given the AGNO PHARMA trademark a serial number of 98787882. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, November 25, 2025. This trademark is owned by AGNO PHARMACEUTICALS LLC. The AGNO PHARMA trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Custom manufacture of pharmaceuticals

Research on the subject of pharmaceuticals; Research and development in the pharmaceutical and biotechnology fields; Laboratory research services relating to pharmaceuticals; Pharmaceutical research and development; Pharmaceutical products development; Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services
agno pharma

General Information


Serial Number98787882
Word MarkAGNO PHARMA
Filing DateMonday, October 7, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, November 25, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 25, 2025

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Translation of Words in MarkThe wording "AGNO" has no meaning in a foreign language.
NOT AVAILABLE"PHARMA"
Description of MarkThe mark consists of the word "AGNO" where the "O" has the design of a pill inside and the word "PHARMA" appears underneath the term "AGNO".
Goods and ServicesCustom manufacture of pharmaceuticals
Goods and ServicesResearch on the subject of pharmaceuticals; Research and development in the pharmaceutical and biotechnology fields; Laboratory research services relating to pharmaceuticals; Pharmaceutical research and development; Pharmaceutical products development; Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateMonday, October 7, 2024
Primary Code040
First Use Anywhere DateFriday, September 13, 2024
First Use In Commerce DateFriday, September 13, 2024

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 7, 2024
Primary Code042
First Use Anywhere DateFriday, September 13, 2024
First Use In Commerce DateFriday, September 13, 2024

Trademark Owner History


Party NameAGNO PHARMACEUTICALS LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBethlehem, PA 18017

Party NameAGNO PHARMACEUTICALS LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBethlehem, PA 18017

Trademark Events


Event DateEvent Description
Monday, October 7, 2024NEW APPLICATION ENTERED
Wednesday, April 9, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 9, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, April 10, 2025ASSIGNED TO EXAMINER
Monday, April 14, 2025NON-FINAL ACTION WRITTEN
Monday, April 14, 2025NON-FINAL ACTION E-MAILED
Monday, April 14, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 14, 2025NON-FINAL ACTION WRITTEN
Monday, April 14, 2025NON-FINAL ACTION E-MAILED
Monday, April 14, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 29, 2025ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, July 29, 2025ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, September 29, 2025TEAS PETITION TO REVIVE RECEIVED
Monday, September 29, 2025PETITION TO REVIVE-GRANTED
Monday, September 29, 2025NOTICE OF REVIVAL - E-MAILED
Monday, September 29, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 29, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 30, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 7, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 7, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 7, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 7, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, October 28, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 19, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 25, 2025PUBLISHED FOR OPPOSITION
Tuesday, November 25, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED